(INTC) Intel - Overview
Stock: Microprocessors, Chipsets, Accelerators, Memory, Edge Platforms
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 68.1% |
| Relative Tail Risk | -13.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.66 |
| Alpha | 135.74 |
| Character TTM | |
|---|---|
| Beta | 1.526 |
| Beta Downside | 1.339 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.80% |
| CAGR/Max DD | 0.37 |
Description: INTC Intel January 27, 2026
Intel Corporation (NASDAQ: INTC) designs, develops, manufactures, markets, and sells a broad portfolio of computing products and services worldwide. Its operations are organized into three segments-Intel Products, Intel Foundry, and All Other-covering microprocessors, chipsets, system-on-chips, multi-chip packages, CPUs, GPUs, accelerators, FPGAs, memory, storage, connectivity, and related silicon and software solutions for AI, security, networking, and edge-to-cloud workloads. The company also provides autonomous-driving technologies, advanced packaging, and ecosystem services for OEMs, ODMs, cloud providers, and other technology partners.
According to Intel’s FY 2025 fourth-quarter earnings release (May 2025), the firm generated $63.1 billion in total revenue, with a 31 % gross margin and $14 billion invested in R&D-up 9 % year-over-year. Intel Foundry reported a 12 % YoY revenue increase, driven by rising demand for custom AI accelerators, while shipments of AI-optimized Xeon processors grew 45 % YoY, reflecting the broader industry shift toward generative-AI workloads. The U.S. CHIPS Act continues to shape the sector; Intel secured roughly $5 billion in federal incentives for its Fab 48 expansion, supporting capacity growth at a time when global data-center spend is projected to rise 8 % annually through 2027 (IDC). These macro drivers suggest a favorable environment for Intel’s advanced-process and AI-centric product lines.
For a deeper quantitative comparison of Intel’s valuation metrics versus peers, the ValueRay platform offers a concise, data-driven dashboard.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -267.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 5.63 > 1.0 |
| NWC/Revenue: 60.76% < 20% (prev 21.95%; Δ 38.80% < -1%) |
| CFO/TA 0.05 > 3% & CFO 9.70b > Net Income -267.0m |
| Net Debt (32.32b) to EBITDA (14.35b): 2.25 < 3 |
| Current Ratio: 2.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.86b) vs 12m ago 12.43% < -2% |
| Gross Margin: 34.77% > 18% (prev 0.33%; Δ 3444 % > 0.5%) |
| Asset Turnover: 25.91% > 50% (prev 27.03%; Δ -1.11% > 0%) |
| Interest Coverage Ratio: 2.43 > 6 (EBITDA TTM 14.35b / Interest Expense TTM 1.09b) |
Altman Z'' 3.25
| A: 0.15 (Total Current Assets 63.69b - Total Current Liabilities 31.57b) / Total Assets 211.43b |
| B: 0.23 (Retained Earnings 48.98b / Total Assets 211.43b) |
| C: 0.01 (EBIT TTM 2.65b / Avg Total Assets 203.96b) |
| D: 1.34 (Book Value of Equity 114.28b / Total Liabilities 85.07b) |
| Altman-Z'' Score: 3.25 = A |
Beneish M -3.07
| DSRI: 1.11 (Receivables 3.84b/3.48b, Revenue 52.85b/53.10b) |
| GMI: 0.94 (GM 34.77% / 32.66%) |
| AQI: 0.95 (AQ_t 0.20 / AQ_t-1 0.21) |
| SGI: 1.00 (Revenue 52.85b / 53.10b) |
| TATA: -0.05 (NI -267.0m - CFO 9.70b) / TA 211.43b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of INTC shares?
Over the past week, the price has changed by +8.87%, over one month by +26.35%, over three months by +35.85% and over the past year by +161.04%.
Is INTC a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 39
- Sell: 2
- StrongSell: 2
What are the forecasts/targets for the INTC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.2 | -6.8% |
| Analysts Target Price | 47.2 | -6.8% |
| ValueRay Target Price | 53.9 | 6.4% |
INTC Fundamental Data Overview February 07, 2026
P/S = 4.7813
P/B = 2.1086
P/EG = 0.5009
Revenue TTM = 52.85b USD
EBIT TTM = 2.65b USD
EBITDA TTM = 14.35b USD
Long Term Debt = 44.09b USD (from longTermDebt, last quarter)
Short Term Debt = 2.50b USD (from shortTermDebt, last quarter)
Debt = 46.59b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.32b USD (from netDebt column, last quarter)
Enterprise Value = 285.03b USD (252.71b + Debt 46.59b - CCE 14.27b)
Interest Coverage Ratio = 2.43 (Ebit TTM 2.65b / Interest Expense TTM 1.09b)
EV/FCF = -57.59x (Enterprise Value 285.03b / FCF TTM -4.95b)
FCF Yield = -1.74% (FCF TTM -4.95b / Enterprise Value 285.03b)
FCF Margin = -9.36% (FCF TTM -4.95b / Revenue TTM 52.85b)
Net Margin = -0.51% (Net Income TTM -267.0m / Revenue TTM 52.85b)
Gross Margin = 34.77% ((Revenue TTM 52.85b - Cost of Revenue TTM 34.48b) / Revenue TTM)
Gross Margin QoQ = 36.15% (prev 38.22%)
Tobins Q-Ratio = 1.35 (Enterprise Value 285.03b / Total Assets 211.43b)
Interest Expense / Debt = 0.61% (Interest Expense 283.0m / Debt 46.59b)
Taxrate = 21.0% (US default 21%)
NOPAT = 2.09b (EBIT 2.65b * (1 - 21.00%))
Current Ratio = 2.02 (Total Current Assets 63.69b / Total Current Liabilities 31.57b)
Debt / Equity = 0.41 (Debt 46.59b / totalStockholderEquity, last quarter 114.28b)
Debt / EBITDA = 2.25 (Net Debt 32.32b / EBITDA 14.35b)
Debt / FCF = -6.53 (negative FCF - burning cash) (Net Debt 32.32b / FCF TTM -4.95b)
Total Stockholder Equity = 104.57b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.13% (Net Income -267.0m / Total Assets 211.43b)
RoE = -0.26% (Net Income TTM -267.0m / Total Stockholder Equity 104.57b)
RoCE = 1.78% (EBIT 2.65b / Capital Employed (Equity 104.57b + L.T.Debt 44.09b))
RoIC = 1.37% (NOPAT 2.09b / Invested Capital 153.09b)
WACC = 9.82% (E(252.71b)/V(299.29b) * Re(11.54%) + D(46.59b)/V(299.29b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 11.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.77%
Fair Price DCF = unknown (Cash Flow -4.95b)
EPS Correlation: -49.75 | EPS CAGR: -37.42% | SUE: 0.28 | # QB: 0
Revenue Correlation: -50.25 | Revenue CAGR: -7.55% | SUE: 0.84 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.00 | Chg30d=-0.051 | Revisions Net=-17 | Analysts=34
EPS current Year (2026-12-31): EPS=0.48 | Chg30d=-0.113 | Revisions Net=-16 | Growth EPS=+14.8% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=0.99 | Chg30d=-0.084 | Revisions Net=-4 | Growth EPS=+105.6% | Growth Revenue=+7.7%